Sep 2026· Journal of Biomedical Informatics· Vol 182, pp.
105100
· 1 citation· 42 references
Medicine
TL;DR
SIGMA-DTA, a similarity-guided adaptive interaction modeling framework for DTA prediction, introduces a similarity-driven routing mechanism that adjusts information propagation under different similarity levels and can model complex drug-target relationships more effectively.
Abstract
Drug-target affinity (DTA) prediction is an important task in computer-aided drug discovery. Existing methods usually use a fixed drug-protein interaction strategy. This design is hard to adapt to heterogeneous samples. It is also limited in cold-start and low-similarity scenarios. This study proposes SIGMA-DTA, a similarity-guided adaptive interaction modeling framework for DTA prediction. The framework uses drug and protein similarities as explicit reasoning priors. It introduces a similarity-driven routing mechanism. The mechanism assigns weights to different interaction paths according to the distance between a sample and the training distribution. This enables sample-specific interaction modeling. Unlike conventional unified interaction schemes, SIGMA-DTA adjusts information propagation under different similarity levels. It can model complex drug-target relationships more effectively. Experiments on the Davis and KIBA datasets verify the effectiveness of the method. The results show that integrating similarity information into the interaction modeling process improves robustness and generalization in DTA prediction.
A systematic reference for future algorithm design, mechanism exploration, and real-world drug discovery applications for AI-driven DTI prediction methodologies, covering binding theories, task formulations, data representation, model design, translational applications, and unresolved challenges.
Jia-Xuan Hu, Lianlian Wu, Song He et al.· Journal of Chemical Informat...· 0 citations
Drug–target affinity (DTA) prediction plays an important role in computational drug discovery; however, its application to emerging infectious diseases such as Ebola remains challenging because of the limited availability of experimentally measured affinity data. To address this low-resource setting, we propose a retri...
Mubarakah Alotaibi, Nada Al Taweraqi· International Journal of Mol...· 0 citations
IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.
Guolongwei Dai, Tao Luo, Dan-Dan Li et al.· ACS Synthetic Biology· 0 citations
MOTIVATION
Cold-start drug-target affinity prediction remains challenging because static interaction mechanisms cannot adapt to individual drug-target pairs.
RESULTS
We propose PCIM-DTA, which constructs pair-level interaction representations and derives a pair-specific condition vector from global drug and target fe...
Zi-You Zhou, Min Chen, Wen-Jia Zhou et al.· Bioinformatics· 3 citations
Empirical evaluation and robustness experiments show that M2DDI maintains high predictive accuracy even when modality-specific information is partially missing, outperforming existing methods under similar conditions and establish M2DDI as an effective and mechanism-aware solution for comprehensive DDI prediction.
Runqing Xu, Siyi Liu, Hao-Yang Li et al.· Proceedings of the 32nd ACM...· 0 citations
A transparent pre-screen can prioritise compounds ahead of structure-based calculation at a fraction of its cost, and the uncertainty and applicability-domain terms act as an abstention mechanism rather than an accuracy gain, and that abstention is not free.
Gozde Yalcin Ozkat· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.